Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-128 in mild to moderate diabetic peripheral neuropathy
NCT00756041Phase 2Terminated
- Sponsor
- Takeda
- Start
- Sep 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of TAK-128 in diabetic peripheral neuropathy (DPN), sponsored by Takeda. Started Sep 2005; status: terminated.
02
Drugs
TAK-128
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00756041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00756041.